[A case of tacrolimus-induced glucose intolerance following renal allografting]. 1995

A Ishikawa, and S Kageyama, and S Mugiya, and T Ushiyama, and K Suzuki, and K Fujita
Department of Urology, Hamamatsu University School of Medicine.

Living renal transplantation (Tx) was carried out on a 41-year-old male undergoing hemodialysis for a six-month period because of end-stage renal failure due to chronic glomerulonephritis. Tacrolimus (FK 506) was used as one of immunosuppressants. The graft worked immediately after Tx. However, his blood sugar level rose extremely high and use of insulin (IS) was required. At the second postoperative day, 0.3 mg/kg/day of FK506 was administered and the trough level (TL) was as high as 65 ng/ml. The serum IS level decreased from the pre-Tx value of 22 microU/ml to 12 microU/ml. With decrease in the dose of FK506, the TL was normalized, and the dose of IS could be decreased. FK506 has been reported to inhibit IS secretion. Therefore, we must be careful to evaluate the blood glucose level in the use of FK506 for patients with poor glucose tolerance.

UI MeSH Term Description Entries
D008297 Male Males
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016559 Tacrolimus A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Anhydrous Tacrolimus,FK-506,FK506,FR-900506,Prograf,Prograft,Tacrolimus Anhydrous,Anhydrous, Tacrolimus,FK 506,FR 900506,FR900506,Tacrolimus, Anhydrous

Related Publications

A Ishikawa, and S Kageyama, and S Mugiya, and T Ushiyama, and K Suzuki, and K Fujita
February 2005, Nihon rinsho. Japanese journal of clinical medicine,
A Ishikawa, and S Kageyama, and S Mugiya, and T Ushiyama, and K Suzuki, and K Fujita
July 1970, Annals of surgery,
A Ishikawa, and S Kageyama, and S Mugiya, and T Ushiyama, and K Suzuki, and K Fujita
January 1966, Surgical forum,
A Ishikawa, and S Kageyama, and S Mugiya, and T Ushiyama, and K Suzuki, and K Fujita
May 1978, Tissue antigens,
A Ishikawa, and S Kageyama, and S Mugiya, and T Ushiyama, and K Suzuki, and K Fujita
February 2005, Nihon rinsho. Japanese journal of clinical medicine,
A Ishikawa, and S Kageyama, and S Mugiya, and T Ushiyama, and K Suzuki, and K Fujita
February 2024, Journal of medical case reports,
A Ishikawa, and S Kageyama, and S Mugiya, and T Ushiyama, and K Suzuki, and K Fujita
September 1997, Hinyokika kiyo. Acta urologica Japonica,
A Ishikawa, and S Kageyama, and S Mugiya, and T Ushiyama, and K Suzuki, and K Fujita
October 1996, Nihon rinsho. Japanese journal of clinical medicine,
A Ishikawa, and S Kageyama, and S Mugiya, and T Ushiyama, and K Suzuki, and K Fujita
January 2017, Case reports in hepatology,
A Ishikawa, and S Kageyama, and S Mugiya, and T Ushiyama, and K Suzuki, and K Fujita
November 1994, The Journal of trauma,
Copied contents to your clipboard!